Raindrop Receives FDA Approval
05 October 2016
This year, I celebrated my20th anniversary of laser vision correction. I first needed glasses for myopia when I was 12, but only wore them in emergencies because I didn't want to look “nerdy.” At age 16, I got gas permeable lenses, which I loved, and later, laser vision correction, because I hated wearing glasses.
Two New Corneal Inlays Increase Options for Presbyopia
27 September 2016
Until recently, the go-to options for treating presbyopia were reading glasses, monovision with either a contact lens or laser vision correction, or multifocal intraocular lenses. Today we now have one more arrow in our quiver: the corneal inlay, which offers patients a safe, less invasive, and reversible alternative to laser vision correction and intraocular lenses.
No More Reading Glasses? New Implant May Help With Aging Eyes
16 September 2016
The Raindrop implant reshapes the cornea to correct nearsightedness. Cheri Eckstadt, of Minnesota, is about to become the first person in the nation to get the newly-approved FDA device.
So long, reading glasses? New Raindrop eye implant could make them obsolete
16 September 2016
Thanks to a new eye implant called the Raindrop, a five-minute procedure could make reading glasses a thing of the past. NBC News medical contributor Dr. John Torres reports on the first patient to undergo the procedure since it received FDA approval.
Pfizer goes local with Russian joint venture - Doing Business With Russia
12 September 2016
The American pharmaceutical corporation is building a new facility south of Moscow to capitalize on support from government initiatives, which is also indicative of its commitment to the local market.
Pfizer goes local with Russian joint venture
07 September 2016
In July 2016, the U.S. pharmaceutical giant Pfizer became the first foreign company in its sector to localize its business in Russia with a Russian partner. Pfizer and the Russian-American company NovaMedica, whose shareholders include the Russian state-owned company Rusnano, decided to jointly invest in the construction of a plant in the Kaluga Region, 125 miles southwest of Moscow.
01 September 2016
Most people begin to notice a decline in their near vision in their early 40s and 50s, which typically occurs as a result of a frustrating but inevitable age-related change in vision called presbyopia. Fortunately, recent advancements in technology provide surgical options to improve near vision and offer patients restored visual independence. On June 29, 2016, The U.S. Food and Drug Administration (FDA) approved the Raindrop® Near Vision Inlay -- a surgical implant produced by ReVision Optics, Inc. -- used to help improve near vision in patients between the ages of 45-65 years old who suffer from presbyopia.
23 August 2016
Following extensive clinical trials, the Food and Drug Administration (FDA) approved the Raindrop Near Vision Inlay, a tiny, clear, implantable medical device, to improve near vision in some patients with presbyopia. FDA approval was granted June 29, 2016.
Follow the Money: US Companies Shrug Off Politics and Invest in Russia
11 August 2016
In spite of the US government's best efforts to sanction the Russian economy, many US companies are continuing or even increasing their investment in Russia, wrote Forbes columnist Kenneth Rapoza.
American Companies Thriving In Russia: Is There Something To Be Ashamed About?
05 August 2016
Ever since the Democratic National Committee decided to turn their disdain for Bernie Sanders into disdain for Russians and Donald Trump, the New York billionaire has been seen as being in bed with Russian oligarchs and longing to cut deals in Moscow. Since when was it so bad to want to do business with the Russians?
05 November 2024
03 November 2024
October 10 – World Mental Health Day
10 October 2024
Siberian State Medical University and Skoltech to start production of bone tissue fillers
22 November 2024
Sechenov University is creating a digital drug reference book
21 November 2024
Skills shortage still holding back pharma's digital transformation: survey
21 November 2024
Trials for Russia’s first CAR-T drug “Utzhefra” have started
20 November 2024